For Animal Health Only
NOVACOC
Perfusion Solution
COMPOSITION: Each ml of clear, golden-orange aqueous solution contains
_cc781905-5cde-3194-bb3b-136bad-136bad5cf3b-136d58359cf1365cf583594cc781905-5cde-3194-bb3b-136bad-136bad5cf1365cf78359cc1365359cc58359cf1365cde78359cc78195 5cde-3194-bb3b-136bad5cf58d_ Metamizole sodium | 40.00mg mg |
_cc781905-5cde-3194-bb3b-136bad-136bad5cf3b-136d58359cf1365cf583594cc781905-5cde-3194-bb3b-136bad-136bad5cf1365cf78359cc1365359cc58359cf1365cde78359cc78195 5cde-3194-bb3b-136bad5cf58d_ _cc7894__cf58d_cc7894cf58d_cc7894_f58cf375cde-3194-bb3b-136bad5cf58d_cc7894__cf58359-cc7894__cf58359cfcf7894_cf58359cc7894cf58cde_cfcf7894cf58359cde-3194-3194-bb3b-36bad5cf58d__cc7894-3194-bb3b-b-36 -3194-bb3b-136bad5cf58d_ | 3.50mgmg |
_cc781905-5cde-3194-bb3b-136bad-136bad5cf3b-136d58359cf1365cf583594cc781905-5cde-3194-bb3b-136bad-136bad5cf1365cf78359cc1365359cc58359cf1365cde78359cc78195 5cde-3194-bb3b-136bad5cf58d_ Calcium gluconate | 100.00mg mg |
_cc781905-5cde-3194-bb3b-136bad-136bad5cf3b-136d58359cf1365cf583594cc781905-5cde-3194-bb3b-136bad-136bad5cf1365cf78359cc1365359cc58359cf1365cde78359cc78195 5cde-3194-bb3b-136bad5cf58d_ Magnesium gluconate | 10.00mg mg |
_cc781905-5cde-3194-bb3b-136bad-136bad5cf3b-136d58359cf1365cf583594cc781905-5cde-3194-bb3b-136bad-136bad5cf1365cf78359cc1365359cc58359cf1365cde78359cc78195 5cde-3194-bb3b-136bad5cf58d_ Sodium dihydrogen phosphate dihydrate | 4.02mgmg |
_cc781905-5cde-3194-bb3b-136bad-136bad5cf3b-136d58359cf1365cf583594cc781905-5cde-3194-bb3b-136bad-136bad5cf1365cf78359cc1365359cc58359cf1365cde78359cc78195 5cde-3194-bb3b-136bad5cf58d_ Acetylethionine | 40.00mg mg |
_cc781905-5cde-3194-bb3b-136bad-136bad5cf3b-136d58359cf1365cf583594cc781905-5cde-3194-bb3b-136bad-136bad5cf1365cf78359cc1365359cc58359cf1365cde78359cc78195 5cde-3194-bb3b-136bad5cf58d_ Glucose monohydrate (18 (equivalent to 1.82mg Glucose) | 200.00 mg mg |
_cc781905-5cde-3194-bb3b-136bad-136bad5cf3b-136d58359cf1365cf583594cc781905-5cde-3194-bb3b-136bad-136bad5cf1365cf78359cc1365359cc58359cf1365cde78359cc78195 5cde-3194-bb3b-136bad5cf58d_ Excipients whose knowledge is essential for the safe use of the preparation: | |
_cc781905-5cde-3194-bb3b-136bad-136bad5cf3b-136d58359cf1365cf583594cc781905-5cde-3194-bb3b-136bad-136bad5cf1365cf78359cc1365359cc58359cf1365cde78359cc78195 5cde-3194-bb3b-136bad5cf58d_ 10.5 mg of benzyl alcohol, boric acid, water for injection |
|
SPECIAL CLINICAL INFORMATION AND SPECIAL WARNINGS FOR TARGET SPECIES:Slow intravenous (IV) infusion should be provided at body temperature by observing the heartbeat. If tachycardia or cardiac arrhythmia occurs, the infusion should be stopped. Attention should be paid to general asepsis and antisepsis during application. Use in pregnancy and lactation: Novacoc can be administered to pregnant women and lactating animals.
UNDESIRED/SIDE EFFECTS
There are no side effects or undesirable effects of the product. If the infusion rate is too high and the solution is at temperatures below body temperature, tachycardia and cardiac arrhythmia may occur.
DRUG INTERACTIONS
Increased amounts of calcium may potentiate the effect of cardiac glycosides and adrenergics (etilephrine). Cardiac arrhythmia may occur as a result of concomitant use with inhalation anesthetics. Metamizole can increase the effect of anticoagulants, weaken the effect of furosemide. Magnesium gluconate weakens the action of aminoglycosides and tetracyclines, and enhances the neuromuscular-blocking effect of aminoglycosides and inhalation anesthetics. Caffeine enhances the action of cardiac glycosides. It should not be mixed with other drugs intended for parenteral administration.
SYMPTOMS OF OVERDOSE, PRECAUTIONS AND ANTIDOTE: Undesirable effects are mainly due to incorrect infusions (if the infusion rate is too high and/or the solution is at temperatures below body temperature). As a result, circulatory collapse, cardiac arrhythmia, labored breathing, spasms, and muscle weakness may develop. In such cases, the infusion is stopped and, if necessary, symptomatic treatment is started.
WARNINGS ABOUT DRUG RESIDUES IN FOOD
Drug Residue Clearance Time (withdrawal); During the treatment and after the last drug application, cattle raised for meat should not be sent to slaughter before 13 days, horses 6 days, and pigs 3 days later. Cow milk obtained during the treatment and until 5 milkings (2.5 days) after the last drug administration should not be offered for human consumption. It is not used in mares producing milk for human consumption.
GENERAL WARNINGS:Consult your veterinarian before use and in case of an unexpected effect.
Keep out of reach of children. Keep away from foodstuffs.
PRECAUTIONS TO BE TAKEN BY THE APPLICANT AND WARNINGS FOR PHYSICIANS:In case of accidental self-injection by the practitioner, a physician should be consulted with the package insert.
Novacoc
Cattle and Horse